author-photo

Jeanne Chapron

Paris Descartes University

50

Papers

460

Citations

Citation Trend

Filter By

Papers (36) Sort By

Journal Conference Others

Prognostic value of the nutritional status in patients with metastatic non-small cell lung cancer treated with immune checkpoints inhibitors

2020 Clinical nutrition ESPEN
Show All
- Source
- Cite
- Save
Citations (0)
Is there an Exposure–Response Relationship for Nivolumab in Real-World NSCLC Patients?

2019 Cancers
Show All
- Source
- Cite
- Save
Citations (16)
Abstract 1693: Prediction of the efficacy of nivolumab using resting energy expenditure in metastatic non-small cell lung cancer (mNSCLC) patients

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Resting energy expenditure in the risk assessment of anticancer treatments

2017 Clinical Nutrition
Show All
- Source
- Cite
- Save
Citations (18)
Predictive and prognostic value of systemic inflammatory response biomarkers in patients receiving nivolumab for metastatic non-small cell lung cancer (NSCLC).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
A multidisciplinary team dedicated to the management of patients treated with PD1 inhibitors: The Cochin hospital experience.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Renin-associated hypertension after bronchial artery embolization in cystic fibrosis

2016 Journal of Cystic Fibrosis
Show All
- Source
- Cite
- Save
Citations (2)
Identification of patients at risk for severe toxicity under PD1 inhibitors: role of sarcopenic overweight

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis

2016 Clinical Respiratory Journal
Show All
- Source
- Cite
- Save
Citations (5)
Evaluation of baseline asymptomatic dysimmunity prevalence in cancer patients receiving monoclonal anti-PD1 antibodies.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)